Simplex Trading
SPRY icon

Simplex Trading’s ARS Pharmaceuticals SPRY Stock Holding History

Simplex Trading’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,092
Closed -$636K – 9678
2025
Q1 		$554K Buy
44,092
+31,786
+258% +$382K ﹤0.01% 3303
2024
Q4 		$129K Sell
12,306
-43,309
-78% -$607K ﹤0.01% 4944
2024
Q3 		$806K Buy
+55,615
New +$661K ﹤0.01% 3120
2024
Q1 		– Sell
-68,157
Closed -$508K – 9829
2023
Q4 		$373K Buy
68,157
+42,006
+161% +$184K ﹤0.01% 4003
2023
Q3 		$98K Buy
+26,151
New +$172K ﹤0.01% 5106
2022
Q3 		– Sell
-39,195
Closed -$193K – 10829
2022
Q2 		$166K Buy
39,195
+38,824
+10,465% +$135K ﹤0.01% 4860
2022
Q1 		$1K Sell
371
-1,776
-83% -$7.73K ﹤0.01% 10147
2021
Q4 		$14K Buy
+2,147
New +$17.4K ﹤0.01% 8762

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Simplex Trading's SPRY Position: Q2 2025 in Review

Simplex Trading sold out of ARS Pharmaceuticals (SPRY) in Q2 2025, closing a stake of 44,092 shares — an estimated $636K sold.

Simplex Trading first reported a position in SPRY in Q4 2021 and held it in 8 quarters. The position peaked at $806K in Q3 2024. 187 funds tracked by Wall St. Rank hold SPRY as of Q2 2025.

  • Simplex Trading reported no remaining ARS Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 44,092 ARS Pharmaceuticals shares in Q2 2025, an estimated $636K.
  • Simplex Trading first reported a position in ARS Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's ARS Pharmaceuticals position peaked at $806K in Q3 2024.
  • 187 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.